Table 1. Demographic and clinical characteristics and biochemical parameters of the fibromyalgia and control groups.
| Fibromyalgia group (n=30) | Control group (n=30) | p | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||
| Age (years) | 37.90 | 9.37 | 38.23 | 8.76 | 0.784 |
| BMI (kg/m2) | 25.81 | 1.98 | 25.74 | 1.93 | 0.824 |
| Duration of disease (years) | 3.06 | 1.51 | – | – | – |
| Tender point count | 14.12 | 2.46 | 1.93 | 0.67 | <0.001 |
| VAS (pain intensity) | 5.85 | 1.26 | 2.57 | 1.09 | <0.001 |
| FIQ score | 58.19 | 9.53 | – | – | – |
| BDI score | 12.31 | 4.02 | 3.55 | 1.90 | <0.001 |
| Glucose (mg/dL) | 92.07 | 10.51 | 91.57 | 9.81 | 0.850 |
| Insulin (μU/mL) | 7.56 | 2.83 | 7.27 | 2.79 | 0.700 |
| GH (ng/mL) | 0.31 | 0.14 | 1.61 | 0.91 | <0.001 |
| Leptin (ng/mL) | 36.34 | 10.04 | 16.18 | 7.40 | <0.001 |
| IGF-1 (ng/mL) | 158.23 | 13.83 | 243.84 | 83.87 | <0.001 |
| IGFBP-3 (ng/mL) | 2561.64 | 597.37 | 2539.00 | 605.24 | 0.885 |
VAS: Visual Analog Scale; FIQ: Fibromyalgia Impact Questionnaire; BDI: Beck Depression Inventory; GH: growth hormone; IGF-1: insulin-like growth factor; IGFBP-3: insulin-like growth factor binding protein-3.